share_log
Reuters ·  Jan 27 21:00
Apellis Receives Approval of Syfovre® (Pegcetacoplan) in Australia for Geographic Atrophy (Ga)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 242

Recommended

Write a comment